-Removed-Moronic. That’s the term that decribes the commissions move.
They’re getting a fair bollocking from every angle. First the vaccine debacle and now this Northern Ireland malarkey.
They were even warned before they opened their gobs and spewed forth stupidity.
Me reckons heads will roll on this one.
@ghost-of-a-duke saidAfter 103.000 deaths...
Leaving aside the fact that the EU temporally lost the plot, would you not agree that Brexit has already demonstrated the maneuverability of an independent state (as opposed to a block of 27) to get vaccines approved and rolled out?
There is something fishy about this vaccine makarkey. The commission’s knee-jerk reaction aside.
@shavixmir saidThe UK secured (and approved) vaccines months before the EU. In what way is that fishy?
After 103.000 deaths...
There is something fishy about this vaccine makarkey. The commission’s knee-jerk reaction aside.
@ghost-of-a-duke saidI couldn’t care less what England does or doesn’t do with the vaccines.
The UK secured (and approved) vaccines months before the EU. In what way is that fishy?
I’m on about the deals made by the EU with the pharma companies. And them not delivering.
@shavixmir saidBecause of the problems in Belgium?
I couldn’t care less what England does or doesn’t do with the vaccines.
I’m on about the deals made by the EU with the pharma companies. And them not delivering.
'AstraZeneca warned the European commission on Friday that there would be a significant shortfall in the promised 100m vaccine doses this quarter, of up to 60%. It says this is due to a technical issue: not enough vaccine is being produced by the main plant making the supplies destined for Europe, which is in Belgium.'
https://www.theguardian.com/world/2021/jan/26/why-has-astrazeneca-cut-vaccines-to-eu-and-will-it-impact-uk-
@ghost-of-a-duke saidThat’s the company’s side of the saga.
Because of the problems in Belgium?
'AstraZeneca warned the European commission on Friday that there would be a significant shortfall in the promised 100m vaccine doses this quarter, of up to 60%. It says this is due to a technical issue: not enough vaccine is being produced by the main plant making the supplies destined for Europe, which is in Belgium.'
https ...[text shortened]... /www.theguardian.com/world/2021/jan/26/why-has-astrazeneca-cut-vaccines-to-eu-and-will-it-impact-uk-
EU officials have questioned it.
I do not know why.
@shavixmir saidThere was a poor yield in Belgium and the EU has been slow off the mark when it came to vaccines. (In a number of key areas). The knee-jerk reaction was a direct result of this.
That’s the company’s side of the saga.
EU officials have questioned it.
I do not know why.
There's no mystery here.